EANO Guideline on the Diagnosis and Treatment of Vestibular Schwannoma

EANO Guideline on the Diagnosis and Treatment of Vestibular Schwannoma

The level of evidence to provide treatment recommendations for vestibular schwannoma is low compared to other intracranial neoplasms. Therefore, the vestibular schwannoma task force of the European Association of Neuro-Oncology assessed the data available in the literature and composed a set of recommendations for health care professionals. The radiological diagnosis of vestibular schwannoma is made by magnetic resonance imaging. Histological verification of the diagnosis is not always required. Current treatment options comprise observation, surgical resection, fractionated radiotherapy and radiosurgery. The choice of treatment depends on clinical presentation, tumor size and expertise of the treating center. In small tumors, observation has to be weighed against radiosurgery, in large tumors surgical decompression is mandatory, potentially followed by fractionated radiotherapy or radiosurgery. Except for bevacizumab in neurofibromatosis type 2, there is no role for pharmacotherapy.

Click here to read published version (Neuro-Oncology, noz153, https://doi.org/10.1093/neuonc/noz153 Published: 28 August 2019)

EANO Conflict of Interest Disclosure

Declarations of potential or actual conflicts of interest, whether due to a financial or other relationship, must be provided. Declarations must include any payments, honorarium or arrangement for re-imbursement of expenses, relevant for any aspect of his/her involvement with EANO, that has been provided by commercial companies.

Log in to edit your data

Login